Rivaroxaban
Overview
Rivaroxaban is an oral anticoagulant used to prevent and treat blood clots. It works as a direct factor Xa inhibitor, which disrupts the blood coagulation cascade.
API suppliers (61)
Suppliers of Rivaroxaban evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 53 of 61 suppliers.
31 of 61 hold a GMP certificate on record in the EU or UK registers · 2 hold a European CEP for this substance
- DR REDDYS LABORATORIES LTD2 active DMF GMP on record
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- GOLD PHARMA PRIVATE LIMITEDIndia1 active DMF
- FUXIN LONG RUI PHARMACEUTICAL CO LTD1 active DMF
- Biocon LimitedIndia1 active DMF
- WANBURY LTDIndia1 active DMF
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- Viyash Scientific LtdIndia1 active DMF GMP on record
- Taro Pharmaceutical Industries Ltd.Israel1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- MEDICHEM MANUFACTURING (MALTA) LTDMalta1 active DMF GMP on record
- INTERQUIM SAPeru1 active DMF GMP on record
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- RAKS PHARMA PVT LTDIndia1 active DMF
- Zhejiang Supor Pharmaceuticals Co., LtdChina1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Tianjin Weijie Pharmaceutical Co., Ltd.China1 active DMF
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- Neuland Laboratories LimitedIndia1 active DMF
- Apotex Inc.Canada1 active DMF
- JUBILANT BIOSYS LTDIndia1 active DMF
- Micro Labs Usa1 active DMF
- COHANCE LIFESCIENCES LTDIndia1 active DMF GMP on record
Showing 25 of 61 suppliers — see the full list in the app.
EU CEP holders (39)
Companies holding a valid EU Certificate of Suitability (CEP) for Rivaroxaban, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Patent & exclusivity (US)
Per the FDA Orange Book (72 approved US products), the latest listed US patent on Rivaroxaban expires 17 Aug 2034. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Rivaroxaban? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.